Disclosure of large shareholding

About this update from Gentian Diagnostics Asa

Oslo, 22 May 2025, Notification of trade Carpe Diem Afseth AS ("Carpe Diem") has today, 22 May 2025, acquired 10,000shares in Gentian Diagnostics ASA ("Gentian"). Following the acquisition,CarpeDiem owns 772,816 shares in Gentian which represents a total of 5.01% ofGentian's issued shares andvoting rights (based on 15,422,350 shares issued by Gentian). Carpe Diem is100%owned by John Afseth who has no formal role in Gentian.This disclosure is made pursuant to section 4-2 of the Norwegian SecuritiesTrading Act and is subject to the disclosure requirement pursuant to section5-12 of the Norwegian Securities Trading Act.https://newsweb.oslobors.no/message/647150

View stock analysis, news, and events for Gentian Diagnostics Asa